Skip to main content
. 2018 Sep 12;105(3):235–242. doi: 10.1136/heartjnl-2018-313351

Figure 1.

Figure 1

The concentrations of fragment 1+2 (F1+2) (A), D-dimer (B), soluble CD40 ligand (sCD40L) (C) and von Willebrand factor (vWF) antigen (D) in the apixabanand warfarin treatment groups stratified by warfarin (vitamin K antagonist (VKA)) status at randomisation. Boxes represent the 25th–75th percentiles with the median marked by a black line. Whiskers represent the 10th and 90th percentiles.